Bell Michael Brian 4

Accession 0001702824-25-000008

CIK 0001576280other

View on SEC.gov Company Profile

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 9:37 PM ET

Size

32.5 KB

Accession

0001702824-25-000008

Insider Transaction Report

Form 4

Period: 2025-12-05

Guardant Health, Inc.GH

Bell Michael Brian

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2025-12-05$32.86/sh+29,382$965,493→ 81,509 total
Exercise/Conversion
Common Stock
2025-12-05$28.37/sh+26,905$763,295→ 108,414 total
Sale
Common Stock
2025-12-05$101.42/sh−8,033$814,736→ 100,381 total
Sale
Common Stock
2025-12-05$102.11/sh−22,891$2,337,302→ 77,490 total
Sale
Common Stock
2025-12-05$103.26/sh−7,567$781,394→ 69,923 total
Sale
Common Stock
2025-12-05$103.96/sh−11,978$1,245,252→ 57,945 total
Sale
Common Stock
2025-12-05$105.82/sh−250$26,454→ 57,695 total
Sale
Common Stock
2025-12-05$106.68/sh−5,568$594,018→ 52,127 total
Sale
Common Stock
2025-12-05$101.46/sh−3,267$331,483→ 48,860 total
Sale
Common Stock
2025-12-05$102.11/sh−8,774$895,932→ 40,086 total
Sale
Common Stock
2025-12-05$103.24/sh−2,533$261,509→ 37,553 total
Sale
Common Stock
2025-12-05$103.96/sh−5,027$522,611→ 32,526 total
Sale
Common Stock
2025-12-05$106.70/sh−3,284$350,408→ 29,242 total
Sale
Common Stock
2025-12-05$107.26/sh−1,190$127,642→ 28,052 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-05−29,382→ 7,137 total
Exercise: $32.86Exp: 2033-06-09→ Common Stock (29,382 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-05−26,905→ 10,421 total
Exercise: $28.37Exp: 2033-12-13→ Common Stock (26,905 underlying)

Footnotes (13)

[F1]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $100.715 to $101.705. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[F10]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.935 to $106.925. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[F11]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.010 to $107.390. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[F12]The stock option vests as to 33% of the shares subject to such award on June 9, 2024, and as to the remaining 67% of the shares subject to such award in substantially equity installments on each monthly anniversary of June 9, 2024, during the two-year period thereafter.
[F13]This represents a stock option granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
[F2]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.715 to $102.690. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[F3]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $102.720 to $103.710. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[F4]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.720 to $104.440. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[F5]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.415 to $106.390. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[F6]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.420 to $106.980. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[F7]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $100.710 to $101.700. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[F8]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.715 to $102.670. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[F9]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.720 to $104.510. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file

4
wk-form4_1765247822.xmlPrimary
FORM 4

Issuer

Guardant Health, Inc.

CIK 0001576280

→

Entity typeother

Related Parties

filerCIK 0001702824

Filing Metadata

Form type: 4
Filed: Dec 7, 7:00 PM ET
Accepted: Dec 8, 9:37 PM ET
Size: 32.5 KB

View on SEC.gov